Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome

Details for Australian Patent Application No. 2006243395 (hide)

Owner Novartis AG

Inventors Mestan, Jurgen; Fabbro, Doriano; Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-B-2006243395

PCT Pub. Number WO2006/117185

Priority 60/676,751 02.05.05 US

Filing date 2 May 2006

Wipo publication date 9 November 2006

Acceptance publication date 11 March 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/117185 Priority application(s): WO2006/117185

11 March 2010 Application Accepted

  Published as AU-B-2006243395

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243402-Pesticidal compositions comprising an azole, a phenylamide and a strobilurin and/or phenylpyrrole fungicide

2006243393-3 -monoand 3 , 5-disubstituted piperidine derivatives as renin inhibitors